Propelled by Rapid Spread of Infection, Global Covid-19 Diagnostics Market to Reach US$17.20 bn by 2022

November 19 02:42 2020
Propelled by Rapid Spread of Infection, Global Covid-19 Diagnostics Market to Reach US$17.20 bn by 2022
COVID-19 DIAGNOSTICS MARKET BY PRODUCT (PCR KITS, POC KITS AND IMMUNOASSAY), TECHNOLOGY (MOLECULAR AND IMMUNOASSAY), AND END USER (HOSPITALS, PHYSICIAN’S OFFICE & URGENT CARE CLINICS AND DIAGNOSTIC LABS): GLOBAL OPPORTUNITY ANALYSIS AND INDUSTRY FORECAST, 2020-2022

A new report on the global Covid-19 diagnostics market has recently been added to the vast base of Report Ocean’s repository. The report is titled “Covid-19 Diagnostics Market by Product (PCR Kits, POC Kits and Immunoassay), Technology (Molecular and Immunoassay), and End User (Hospitals, Physician’s office & urgent care clinics and Diagnostic Labs): Global Opportunity Analysis and Industry Forecast, 2020–2022.”

 GET SAMPLE COPY @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1250

The global Covid 19 diagnostics market is undergoing a phase of transition. The overall valuation of this market is estimated to reach US$17.20 mn by the end of 2020. A detailed overview of this market has been offered in the research report, emphasizing on the main factors impacting the market’s growth. The trends, influencing the growth of this market, have been examined thoroughly to estimate the future size and valuation of this market.

The ongoing Covid 19 pandemic has sent the world into a frenzy. Since this is an easily transmittable infection, can be fatal at times, and there is no cure available till date, people are increasing being concerned regarding its diagnosis. The high mortality rate has spiked the demand for early detection of this infection, leading to a significant rise in the global Covid-19 diagnostics market. Furthermore, constant technological developments and continuous launch of test kits by companies worldwide is propelling the market’s growth.

While the shortage of diagnosis kits in developing economies may act as a hindrance in the near future, the high number of patients in these economies is expected to offer lucrative growth prospects for pharma companies over the next few years.

This research report performs the assessment of the industry chain supporting the worldwide market for Covid-19 diagnostics and provides accurate information about various aspects, such as the production capacity, effective usage of the available products, supply chain, and the rules and policies that influence the market for Covid-19 diagnostics across the world. The exhaustive information achieved through detailed and thorough primary and secondary research techniques has been compiled in this market study. The information, thus sourced, is assessed using the market-best analytical tools. Based on data obtained from such in-depth research, the report includes refined forecasts for the market. Further, the research study forecasts the size and valuation of this market for the next few years.

The research study assesses the global Covid-19 diagnostics market on the basis of the product, technology, end user, and the region. Based on the product, the market has been classified into PCR kits, POC kits, and immune assay. The consumption of PCR kits is relatively higher than the other two products available in the market. By technology, the market has been segmented into molecular technology and immunoassay. Based on the end user, hospitals, diagnostic labs, and physicians’ office and urgent care centers have surfaced as prominent segments of this market. Geographically, the worldwide market for Covid-19 diagnostics has been considered to spread across North America, Europe, Asia Pacific, and LAMEA in this study.

Key Findings:

  • The consumption of PCR kits is relatively higher than the other two products.
  • The shortage of diagnosis kits in developing economies may act as a hindrance.

The global Covid-19 diagnostics market is segmented into:

By Product

  • PCR Kits
  • POC Kits
  • Immuno Assay

By Technology

  • Molecular
  • Immunoassay

By End User

  • Hospitals
  • Physician’s office and urgent care clinics
  • Diagnostic Labs

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Sweden
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Korea
    • Australia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Turkey
    • Rest of LAMEA

Companies Mentioned in the Report

  • F. Hoffmann-La Roche AG
  • Seegene Inc.
  • Cepheid
  • Mylab Lifesolutions Pvt. Ltd.
  • SureScreen Diagnostics Ltd
  • Thermo Fisher Scientific
  • Genematrix
  • Robert Bosch GmbH
  • Cellex

READ FULL REPORT @ https://www.reportocean.com/industry-verticals/sample-request?report_id=AMR1250

Media Contact
Company Name: Report Ocean
Contact Person: Nishi Sharma
Email: Send Email
Phone: +91-9997112116
Address:BSI Business Park,H-15, Sector-63, Noida
City: Noida
State: UP, 201301
Country: India
Website: www.reportocean.com


Warning: count(): Parameter must be an array or an object that implements Countable in /home/dimapurnewsdesk/delhi-today.com/wp-content/themes/gadgetine-theme/includes/single/post-tags-categories.php on line 7